TF5Thymosin Fraction 5 (immunotherapy)
References in periodicals archive ?
TF3 is made up of two anti-CD20 antibody fragments linked to one anti-CD22 antibody fragment, whereas TF5 was constructed by fusing two anti-CD22 antibody fragments to one anti-CD20 fragment.
TF3 and TF5 were shown to be stable in both human and mouse sera.
Available from Lin Chapman, 23 Donnerville Gardens, Admaston, Telford, Shropshire TF5 ODE, United Kingdom.